Michael C. Heck

发表

Inhibition of PKR by RNA and DNA viruses.

J. M. Cameron, J. Langland, B. Jacobs, 2006, Virus research.

Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN).

P. Jurutka, J. Ziller, A. van der Vaart, 2016, Journal of medicinal chemistry.

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination.

J. Langland, B. Jacobs, C. Baskin, 2008, Vaccine.

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.

A. Mercer, B. Jacobs, Michael C. Heck, 2008, Vaccine.

The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.

J. M. Cameron, B. Jacobs, Michael C. Heck, 2005, Virology.

Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.

J. Langland, B. Jacobs, Michael C. Heck, 2017, Virology.

Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

R. Buller, B. Jacobs, P. Verardi, 2013, PloS one.

Role of RcsF in Signaling to the Rcs Phosphorelay Pathway in Escherichia coli

N. Majdalani, S. Gottesman, V. Stout, 2005, Journal of bacteriology.

Retinoid X Receptor Selective Agonists and their Synthetic Methods.

P. Jurutka, Michael C. Heck, P. Marshall, 2017, Current topics in medicinal chemistry.

SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation

Zainab N. Khan, E. Jacobs, M. Galligan, 2017, The Journal of Steroid Biochemistry and Molecular Biology.